JPMorgan Chase & Co’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-49
| Closed | – | – | 6191 |
|
|
2022
Q1 | $0 | Buy |
+49
| New | – | ﹤0.01% | 6194 |
|
|
2021
Q4 | – | Sell |
-185
| Closed | -$1K | – | 6122 |
|
|
2021
Q3 | $1K | Sell |
185
-4,972
| -96% | -$26.9K | ﹤0.01% | 5485 |
|
|
2021
Q2 | $31K | Sell |
5,157
-19,960
| -79% | -$120K | ﹤0.01% | 5056 |
|
|
2021
Q1 | $305K | Buy |
25,117
+12,025
| +92% | +$146K | ﹤0.01% | 4292 |
|
|
2020
Q4 | $191K | Buy |
13,092
+11,210
| +596% | +$164K | ﹤0.01% | 4159 |
|
|
2020
Q3 | $20K | Buy |
+1,882
| New | +$20K | ﹤0.01% | 4490 |
|